New Jersey on Thursday filed a lawsuit against the pharmaceutical company Insys Therapeutics Inc., alleging the company engaged in a “greed-driven” campaign of consumer fraud and false claims to health insurance carriers to increase its sales for Subsys, a fentanyl-based opioid used to treat cancer-related pain.
The Division of Consumer Affairs, a branch of the state Division of Law and Public Safety, filed the lawsuit against the Chandler, Arizona-based company in Middlesex County Superior Court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
